Terms: = Thyroid cancer AND CBLB, DKFZp686J10223, 868, ENSG00000114423, Nbla00127, RNF56, FLJ41152, FLJ36865, DKFZp779F1443, DKFZp779A0729 AND Prognosis
4 results:
1. A 6 transcription factors-associated nomogram predicts the recurrence-free survival of thyroid papillary carcinoma.
Wang T; Tian K; Ji X; Song F
Medicine (Baltimore); 2021 Oct; 100(40):e27308. PubMed ID: 34622829
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic factors for incomplete response in thyroid microcarcinoma: an analysis of initial response to therapy in 517 patients.
Faro FN; Simões VRF; Ricardo GP; Cabral CP; de Cássia Braga Ribeiro K; Scalissi NM; Cury AN; Marone MM; do Prado Padovani R; Ferraz C
Arch Endocrinol Metab; 2021 Oct; 65(5):579-587. PubMed ID: 33740337
[TBL] [Abstract] [Full Text] [Related]
3. Benefits of marriage on relative and conditional relative cancer survival differ between males and females in the USA.
Merrill RM; Johnson E
J Cancer Surviv; 2017 Oct; 11(5):578-589. PubMed ID: 28770444
[TBL] [Abstract] [Full Text] [Related]
4. Papillary microcarcinoma in comparison with larger papillary thyroid carcinoma in BRAF(V600E) mutation, clinicopathological features, and immunohistochemical findings.
Park YJ; Kim YA; Lee YJ; Kim SH; Park SY; Kim KW; Chung JK; Youn YK; Kim KH; Park DJ; Cho BY
Head Neck; 2010 Jan; 32(1):38-45. PubMed ID: 19475551
[TBL] [Abstract] [Full Text] [Related]
